The Melvin Yahr Parkinson’s Disease Clinical Research Award is jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD). This award is designed to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. By recognizing and honoring the exceptional contributions of young talented individuals, the award seeks to break down barriers and create a more inclusive and diverse healthcare community. It is expected that this initiative will spur innovation and promote the translation of cutting-edge scientific discoveries into efficient and practical health measures that will benefit people with Parkinson’s disease.
This award honors Dr. Melvin Yahr, a leader in PD care and research who, with the Foundation’s support, played a seminal role in establishing levodopa as the gold standard symptomatic therapy for PD. In addition to his groundbreaking research, Dr. Yahr also served as a champion of young neurologists, particularly women and other under-represented groups. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.
This is a 1-year award for a total of $50,000. Funds can be used to support research expenses such as salary support for additional trained personnel (e.g., research assistants, study coordinators), equipment or consumables specifically needed for the research plan. Indirect costs are not allowed.
Deadline: 12 February 2026